Optimizing Photosensitizer Delivery for Effective Photodynamic Inactivation of Under Lung Surfactant Conditions.

is a Gram-negative, encapsulated bacterium recognized by the World Health Organization (WHO) as a critical priority for new therapeutic strategies due to its increasing multidrug resistance (MDR). Antimicrobial photodynamic therapy (aPDT) has emerged as a promising alternative to antibiotics, exhibiting a broad spectrum of action and multiple molecular targets, and has been proposed for the treatment of clinically relevant infections such as pneumonia. However, despite excellent in vitro photodynamic inactivation outcomes, the success of in vivo therapy still faces challenges, particularly due to the presence of lung surfactant (LS) in the alveoli.

Unlocking New Porphyrin Aminoacid Bioconjugates with a Pd-Catalyzed Carboxamide Synthesis.

This study introduces a novel approach for the one-step preparation of carboxamide porphyrin-amino acid bioconjugates via palladium/xantphos-catalyzed aminocarbonylation of 5,15-dibromo-10,20-diphenylporphyrin and 5,10,15,20-tetrakis(4-bromophenyl)porphyrin, under relatively mild conditions (70-100 °C, 1 atm CO), using natural amino acid methyl ester derivatives as N-nucleophiles. This optimized methodology leads to different families of amphiphilic porphyrin bioconjugates containing between one and four amino acids through carboxamide bonds, with isolated yields up to 71%. The resulting porphyrin-amino acid conjugates incorporate glycine, alanine, phenylalanine, and valine, offering tunable molecular weights and functional properties tailored to diverse applications.

Efficient and Selective, In Vitro and In Vivo, Antimicrobial Photodynamic Therapy with a Dicationic Chlorin in Combination with KI.

Various cationic photosensitizers employed in antimicrobial photodynamic therapy (aPDT) have the ability to photoinactivate planktonic bacteria under conditions of low phototoxicity to mammalian cells and without generating antimicrobial resistance (AMR). However, the photoinactivation of biofilms requires orders-of-magnitude higher photosensitizer concentrations, which become toxic to host cells. Remarkably, the bactericidal effect of a dicationic di-imidazolyl chlorin toward planktonic and was observed in this work for concentrations below 400 nM under illumination at 660 nm and below 50 μM for the corresponding biofilms.

Repurposing anti-cancer porphyrin derivative drugs to target SARS-CoV-2 envelope.

Antiviral medicines to treat COVID-19 are still scarce. Porphyrins and porphyrin derivatives (PDs) usually present broad-spectrum antiviral activity with low risk of resistance development. In fact, some PDs are clinically approved to be used in anti-cancer photodynamic therapy and repurposing clinically approved PDs might be an alternative to treat COVID-19.

Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers.

The COVID-19 pandemic exposes our vulnerability to viruses that acquire the ability to infect our cells. Classical disinfection methods are limited by toxicity. Existing medicines performed poorly against SARS-CoV-2 because of their specificity to targets in different organisms.